. "11" . . . . . . . . . . . _:b671877338 . . . . "MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy" . "10.3389/fimmu.2020.01091" . . . "Frontiers Media SA" . . . . "10.3389/fimmu.2020.01091" . "9c9097ba5e1bd25fbafa6021eca718f106434b7d" . . "11" . . . . . . . . . . "2020-05-19"^^ . . . . . . . _:b671877338 "2025-01-09T08:02:42.826262"^^ . . . . . . . _:b671877338 . . . . _:b671877338 . . . . . . . . "10.3389/fimmu.2020.01091" . . . . . . . . . . . . . . . . . . . . _:b671877338 . . . . . _:b671877338 .